ILMN
$ILMN
Illumina, Inc.
Leading genomic sequencing and DNA microarray technology company advancing precision medicine.
HealthcareSubscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
ILMN: Sequencing Recovery, Valuation Check
Illumina ($ILMN) shows solid profitability and analyst support, but elevated valuation and mixed momentum warrant a cautious stance. This report walks through the fundamentals, risks, and catalysts ahead of Q1 2026 earnings.
Apr 6, 2026